Skip to content

Infertility and Pregnancy Outcomes of Fertility Spared Gynecological Oncology Patients

The Evaluation of Infertility and Pregnancy Outcomes, as Well as the Assessment of Quality of Life Using WHOQoL and FertiQoL, in Cases of Gynecological Malignancies That Have Undergone Fertility-sparing Surgery(FSS)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05823194
Enrollment
50
Registered
2023-04-21
Start date
2022-12-01
Completion date
2023-06-01
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility Disorders, Gynecologic Cancer

Keywords

fertility sparing, gynecologic malignancy, quality of life, infertility

Brief summary

FSS which aims to preserve a woman's fertility while still effectively treating the cancer, has become an increasingly popular option for young women diagnosed with these types of cancers. It is important to assess how FSS affects a woman's reproductive health, sexual function, psychological well-being, and overall quality of life. This research aims to provide valuable insights into the long-term effects of FSS on a woman's life, and can help healthcare providers make informed decisions about the best treatment options for their patients.

Detailed description

This is a prospective cohort study that aims to evaluate the infertility and pregnancy outcomes, as well as the quality of life of women who underwent fertility-sparing surgery for gynecological malignancies. The study included a comprehensive evaluation of the participants' medical history, surgical procedures, oncological treatment, and fertility preservation methods. Participants recruited from a tertiary care hospital, and women diagnosed with gynecological malignancies (e.g. cervical, ovarian, endometrial cancer) who underwent fertility-sparing surgery between 2010 and 2022. Women who have undergone total hysterectomy, bilateral salpingo-oophorectomy, or adjuvant oncological treatment were excluded from the study. Participants were contacted by phone and asked to complete questionnaires to assess their quality of life using the WHOQoL-BREF and FertiQoL scales.

Interventions

PROCEDUREFertility sparing surgery

Sparing the uterus and/or ovaries of the patients suffering from gynecologic malignancies to keep the patients' fertility

Sponsors

Acibadem University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study included a comprehensive evaluation of the participants' medical history, surgical procedures, oncological treatment, and fertility preservation methods.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of gynecologic cancer, and being fertile in the meantime * Applying directly to gynecologic oncology department * Demand of preserving the fertility

Exclusion criteria

* Having hysterectomy prior to the diagnosis * Having bilateral ooferectomy prior to the diagnosis * Being in menopause * Not accepting to fill the survey * High stage disease which is not able to have FSS

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pregnancy of patients received FSSIn 12 years after FSSIncidence and rate of patients getting pregnant after FSS
Rate of pregnancy after FSS of patients seeking fertility by applying to IVF clinicsIn 12 years after FSSRate of patients referring to IVF clinic after FSS

Secondary

MeasureTime frameDescription
Satisfaction assesed by WHO-QoL Bref and decision-regret scale after FSS12 years% of patients' satisfaction via Quality of life after the surgery, and decision-regret analysis regarding to fertility sparing by the validated questionnaires

Countries

Turkey (Türkiye)

Contacts

Primary ContactNAZLI ALBAYRAK, MD
albayraknazli@gmail.com00905054111626

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026